Beyond COVID-19: Risk and regulatory

US: Proposed COVID-19 legislation would pause merger activity

Representatives wrote to US House leadership requesting that the next stimulus bill include a moratorium on transactions that do not involve firms that are truly failing.

United States | Publication | May 06, 2020

Germany: To save competition: Rethinking exceptions to the ban on cartels

The COVID-19 (coronavirus) crisis has disrupted the conditions for effective competition in several markets.

Global | Publication | May 06, 2020

Australia: COVID-19 and regulatory implications for superannuation

The exponential growth and impact of COVID-19 has not only affected most industries and our everyday lives, but in particular has had significant repercussions within the superannuation industry. In this update, we make some general observations and examine the responses from the key Australian regulators and what this means for superannuation trustees, as well as their directors and senior management.

Australia | Publication | May 06, 2020

Internal investigations and disclosure of sensitive information

Companies conduct internal investigations for a variety of reasons. Internal complaints, legal actions or regulatory investigations, for instance, may trigger internal investigations.

Canada | Publication | May 04, 2020

Canada: Considerations when advertising the health benefits of your products

At the beginning of the COVID-19 pandemic, both Health Canada and the Competition Bureau were quick to issue statements indicating they would continue to monitor the marketplace for false, misleading or deceptive marketing activities related to products claiming they could prevent, treat or cure the virus.

Canada | Publication | April 30, 2020

US: Treasury announces pre-forgiveness audit of PPP loans over $2 million, further eligibility restrictions on private companies

The Small Business Administration will audit all PPP loans over $2 million before providing any loan forgiveness to these borrowers.

United States | Publication | April 29, 2020

Procurement in the Australian infrastructure sector: Protecting against insolvency risk in uncertain times

Australia: Procurement in the infrastructure sector: Protecting against insolvency risk in uncertain times

The economic impact of COVID-19 on the infrastructure sector is vast and, whilst helpful, the Australian Government’s recently introduced temporary relief for financially distressed businesses will not be enough to ensure the ongoing viability of many businesses.

Australia | Publication | April 27, 2020

US: DOJ continues to greenlight coronavirus medical collaborations

The US DOJ again announces it won’t challenge an ongoing collaboration among competitors and government agencies to provide essential COVID-19 healthcare supplies.

United States | Publication | April 23, 2020

Australia: Managing environmental risk during the COVID-19 crisis: A Queensland perspective

The emergence and spread of COVID-19 has had far reaching impacts on public health, the economy and our way of life. Social distancing, travel restrictions, border closures and other emergency requirements have affected businesses around the globe.

Australia | Publication | April 22, 2020